Evolent Health, Inc - stock earnings
EVH Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| July 31, 2024 BeforeMarket | - / - | 597.0 million | - / 631.8 million | 643.0 million |
EVH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -17.3 million USD | 639.7 million USD |
| 2023Q4 | -33.4 million USD | 556.1 million USD |
| 2023Q3 | -25.3 million USD | 511.0 million USD |
| 2023Q2 | -34.3 million USD | 469.1 million USD |
| 2023Q1 | -20.0 million USD | 427.7 million USD |
| 2022Q4 | -11.3 million USD | 382.4 million USD |
| 2022Q3 | 2.1 million USD | 352.6 million USD |
| 2022Q2 | -4.1 million USD | 319.9 million USD |
| 2022Q1 | -5.4 million USD | 297.1 million USD |
| 2021Q4 | -5.6 million USD | 248.4 million USD |
| 2021Q3 | -13.0 million USD | 222.5 million USD |
| 2021Q2 | -9.1 million USD | 222.1 million USD |
| 2021Q1 | -9.8 million USD | 215.1 million USD |
| 2020Q4 | -14.6 million USD | 271.9 million USD |
| 2020Q3 | -37.3 million USD | 264.6 million USD |
| 2020Q2 | -203.5 million USD | 238.6 million USD |
| 2020Q1 | -77.8 million USD | 247.3 million USD |
| 2019Q4 | -198.1 million USD | 236.5 million USD |
| 2019Q3 | -25.5 million USD | 220.1 million USD |
| 2019Q2 | -31.6 million USD | 192.0 million USD |
| 2019Q1 | -46.7 million USD | 197.8 million USD |
| 2018Q4 | -16.7 million USD | 193.1 million USD |
| 2018Q3 | -12.4 million USD | 149.9 million USD |
| 2018Q2 | -9.9 million USD | 144.3 million USD |
| 2018Q1 | -13.6 million USD | 139.7 million USD |
| 2017Q4 | -13.2 million USD | 113.7 million USD |
| 2017Q3 | -12.6 million USD | 107.9 million USD |
| 2017Q2 | -16.9 million USD | 107.1 million USD |
| 2017Q1 | -18.0 million USD | 106.2 million USD |
| 2016Q4 | -17.4 million USD | 88.0 million USD |
| 2016Q3 | -11.2 million USD | 60.2 million USD |
| 2016Q2 | -8.4 million USD | 56.5 million USD |
| 2016Q1 | -122.8 million USD | 49.4 million USD |
| 2015Q4 | -4.1 million USD | 46.1 million USD |
| 2015Q3 | -12.0 million USD | 40.4 million USD |
| 2015Q2 | 359.0 million USD | 10.4 million USD |
| 2015Q1 | -19.3 million USD | 37.0 million USD |
| 2014Q4 | -10.7 million USD | 100.9 million USD |
| 2014Q3 | -3.2 million USD | ? USD |
| 2014Q2 | -5.9 million USD | ? USD |
| 2014Q1 | -11.6 million USD | 20.1 million USD |
| 2013Q4 | 25.1 million USD | -1.9 million USD |
| 2013Q3 | ? USD | 14.6 million USD |
| 2013Q2 | ? USD | 7.5 million USD |
| 2013Q1 | ? USD | 5.5 million USD |
EVH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -113.0 million USD | 2.0 billion USD |
| 2022 | -18.7 million USD | 1.4 billion USD |
| 2021 | -30.3 million USD | 908.0 million USD |
| 2020 | -334.2 million USD | 1.0 billion USD |
| 2019 | -305.6 million USD | 846.4 million USD |
| 2018 | -52.7 million USD | 627.1 million USD |
| 2017 | -60.7 million USD | 435.0 million USD |
| 2016 | -159.7 million USD | 254.2 million USD |
| 2015 | 332.5 million USD | 96.9 million USD |
| 2014 | -25.2 million USD | 100.9 million USD |
| 2013 | 20.0 million USD | 25.7 million USD |
| 2012 | -19.3 million USD | 8.3 million USD |
EVH
Price: $23.07
52 week price:
Earnings Per Share: -1.26 USD
P/E Ratio: -29.50
Exchange: NYQ
Sector: Healthcare
Industry: Health Information Services
Volume: 198391
Ebitda: -6.2 millionMarket Capitalization: 2.7 billion